Xolair (omalizumab)

Xolair-740

Xolair® (omalizumab) is an injectable prescription medicine for the treatment of people with moderate to severe persistent allergic asthma and chronic idiopathic urticaria (CIU).

In the U.S., Genentech, Inc. and Novartis Pharmaceuticals Corporation work together to develop and co-promote Xolair.